Every AI newsletter,Tigermed Pharmaceuticals (SZ 300347, closing price: 185.18 yuan) issued an announcement on the evening of June 15 that the 2019 restricted stock incentive plan granted for the first time a total of 395 incentive objects that meet the conditions for lifting the second sales restriction period. A total of 1,594,517 restricted stocks can be lifted, accounting for 0.18% of the company’s total share capital of 872,466,954 shares on the disclosure date of this announcement. The release of the restricted shares can be listed for circulation on June 21, 2021.
The chairman of Tigermed is Ye Xiaoping, male, 58 years old, Chinese nationality, no permanent residency abroad, and doctoral degree. The general manager of Tigermed is Cao Xiaochun, female, 52 years old, Chinese nationality, no permanent residency abroad, bachelor degree.
1. Tigermed’s holdings of northbound funds have decreased by 3.6608 million shares in the past 30 days, and the proportion of shares in circulation has decreased by 0.46%;
2. No organization has conducted investigations on Tigermed in the past 30 days.
(Reporter Zeng Jianhui)
Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. According to this operation, at your own risk.
Real-time query of global new pneumonia epidemic
Copyright Notice
1This article is the original work of “Daily Economic News”.
2
Without the authorization of “Daily Economic News”, it may not be used in any way, including but not limited to reprinting, extracting, copying or creating mirror images, etc., offenders must be investigated.
3Copyright cooperation telephone: 021-60900099.